CAPLIN POINT LAB LTD. (CAPLIPOINT) financials

CAPLIN POINT LAB LTD. (CAPLIPOINT) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]

Market Cap: ₹17,493Cr.
Current Price: ₹2,301
Stock P/E: 41.7
ROE: 20.4%
ROCE: 26.5%
Book Value: ₹270
Dividend Yield: 0.35%
52W High / Low: ₹2,991/1,500

In Jun 2026, CAPLIN POINT LAB LTD. (CAPLIPOINT) reported sales ₹203 Cr and net profit ₹120 Cr.

Annual TTM: sales ₹759 Cr, net profit ₹420 Cr.

Shareholding: Promoters 70.57% (Jun 2026), FIIs 5.76% (Jun 2026), DIIs 2.49% (Jun 2026), Public 21.19% (Jun 2026), No. of Shareholders 94,385% (Jun 2026).

CAPLIPOINT quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	208	185	174	183	175	189	191	203
Expenses	110	108	99	96	99	98	108	109
Operating Profit	98	77	75	87	76	92	84	94
OPM %	47%	42%	43%	47%	43%	48%	44%	47%
Other Income	43	29	41	32	59	32	61	63
Interest	0	0	0	0	0	0	0	0
Depreciation	6	6	6	6	6	6	7	7
Profit before tax	135	100	110	112	129	117	138	151
Tax %	21%	25%	21%	24%	20%	25%	20%	20%
Net Profit	106	75	86	86	103	87	110	120
EPS in Rs	13.91	9.83	11.38	11.30	13.50	11.48	14.41	15.84
Raw PDF	—	—	—	—	—	—	—	—

CAPLIPOINT profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	528	483	528	529	625	752	738	759
Expenses	321	269	308	308	337	417	396	413
Operating Profit	207	214	220	220	288	336	342	346
OPM %	39%	44%	42%	42%	46%	45%	46%	46%
Other Income	66	19	56	99	105	131	191	215
Interest	0	0	0	0	0	0	0	0
Depreciation	20	22	26	26	27	25	25	26
Profit before tax	253	210	250	293	366	442	508	534
Tax %	22%	26%	25%	20%	22%	23%	22%	—
Net Profit	198	156	188	234	284	339	397	420
EPS in Rs	26.13	20.65	24.79	30.86	37.36	44.66	52.17	55.23
Dividend Payout %	10%	15%	16%	15%	13%	13%	15%	—

CAPLIPOINT balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	15	15	15	15	15	15	15	15
Reserves	417	585	744	915	1,125	1,375	1,686	2,035
Borrowings	1	2	1	1	1	1	2	2
Other Liabilities	107	89	101	123	162	131	112	159
Total Liabilities	539	691	861	1,054	1,303	1,522	1,814	2,212
Fixed Assets	138	167	183	162	157	166	205	223
CWIP	9	4	1	3	43	28	21	9
Investments	168	196	149	265	485	584	802	1,047
Other Assets	225	325	528	624	618	745	786	932
Total Assets	539	691	861	1,054	1,303	1,522	1,814	2,212

CAPLIPOINT cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	107	87	295	231	157	111	196	203
Cash from Investing Activity	-76	-41	-4	-276	-86	-118	-139	-213
Cash from Financing Activity	-15	-33	-3	-23	-30	-34	-38	-46
Net Cash Flow	16	13	287	-68	41	-41	19	-56
Free Cash Flow	47	38	252	224	98	88	139	159
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	79%	66%	163%	133%	101%	69%	89%	92%

CAPLIPOINT shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	70.56%	70.56%	70.56%	70.56%	70.57%	70.57%	70.57%	70.57%
FIIs	3.71%	4.86%	5.73%	6.16%	6.51%	6.58%	6.15%	5.76%
DIIs	1.83%	2.11%	2.00%	2.22%	2.10%	2.05%	2.14%	2.49%
Public	23.93%	22.48%	21.72%	21.06%	20.82%	20.81%	21.14%	21.19%
No. of Shareholders	96,123	92,702	96,387	94,169	93,753	93,705	93,896	94,385

CAPLIPOINT key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	85	151	74	37	61	75	85	131
Inventory Days	36	34	47	76	95	153	102	137
Days Payable	92	79	131	116	130	140	93	148
Cash Conversion Cycle	30	107	-10	-2	26	89	93	120
Working Capital Days	62	137	60	96	23	76	97	140
ROCE %	55%	48%	30%	29%	28%	29%	29%	26%

CAPLIPOINTUpdated 18 Oct 2026, 5:14

Caplin Point Lab Ltd.

CAPLIPOINTUpdated 18 Oct 2026, 5:14

Market Cap

₹17,493Cr.

Current Price

₹2,301

High / Low

₹2,991/1,500

Stock P/E

41.7

ROE20.4%

ROCE26.5%

Book Value₹270

Face Value₹2.00

Dividend Yield0.35%

About

Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	174	97	27	7	97	22	76	10.04
Sep 2023	179	90	24	7	107	23	82	10.81
Dec 2023	133	70	18	7	74	26	55	7.3
Mar 2024	139	82	36	7	87	20	70	9.2
Jun 2024	186	104	22	6	97	25	73	9.54
Sep 2024	208	110	43	6	135	21	106	13.91
Dec 2024	185	108	29	6	100	25	75	9.83
Mar 2025	174	99	41	6	110	21	86	11.38
Jun 2025	183	96	32	6	112	24	86	11.3
Sep 2025	175	99	59	6	129	20	103	13.5
Dec 2025	189	98	32	6	117	25	87	11.48
Mar 2026	191	108	61	7	138	20	110	14.41
Jun 2026	203	109	63	7	151	20	120	15.84

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2015	240	1	183	3	8	51	19	41	5.42
Mar 2016 9m	231	0	169	3	7	58	22	45	6
Mar 2017	342	0	248	13	13	93	24	70	9.3
Mar 2018	427	1	284	23	19	146	30	102	13.53
Mar 2019	537	0	348	35	21	203	27	148	19.59
Mar 2020	528	0	321	66	20	253	22	198	26.13
Mar 2021	483	0	269	19	22	210	26	156	20.65
Mar 2022	528	0	308	56	26	250	25	188	24.79
Mar 2023	529	0	308	99	26	293	20	234	30.86
Mar 2024	625	0	337	105	27	366	22	284	37.36
Mar 2025	752	0	417	131	25	442	23	339	44.66
Mar 2026	738	0	396	191	25	508	22	397	52.17
TTM	759	0	413	215	26	534	—	420	55.23

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	70.57%
FIIs	5.76%
DIIs	2.49%
Public	21.19%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	70.62%	3.09%	0.21%	26.08%
Dec 2023	70.62%	2.84%	0.43%	26.11%
Mar 2024	70.62%	3.33%	1.08%	24.95%
Jun 2024	70.56%	3.38%	1.49%	24.59%
Sep 2024	70.56%	3.71%	1.83%	23.93%
Dec 2024	70.56%	4.86%	2.11%	22.48%
Mar 2025	70.56%	5.73%	2%	21.72%
Jun 2025	70.56%	6.16%	2.22%	21.06%
Sep 2025	70.57%	6.51%	2.1%	20.82%
Dec 2025	70.57%	6.58%	2.05%	20.81%
Mar 2026	70.57%	6.15%	2.14%	21.14%
Jun 2026	70.57%	5.76%	2.49%	21.19%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Jun 2015	15	79	2	128	223	111	31	1	80	223
Mar 2016	15	113	2	132	263	143	0	1	118	263
Mar 2017	15	185	1	116	317	152	3	19	143	317
Mar 2018	15	280	1	115	411	169	15	48	178	411
Mar 2019	15	417	1	107	539	138	9	168	225	539
Mar 2020	15	585	2	89	691	167	4	196	325	691
Mar 2021	15	744	1	101	861	183	1	149	528	861
Mar 2022	15	915	1	123	1054	162	3	265	624	1054
Mar 2023	15	1125	1	162	1303	157	43	485	618	1303
Mar 2024	15	1375	1	131	1522	166	28	584	745	1522
Mar 2025	15	1686	2	112	1814	205	21	802	786	1814
Mar 2026	15	2035	2	159	2212	223	9	1047	932	2212

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Jun 2015	50	-24	-9	17
Mar 2016	44	-6	-14	24
Mar 2017	55	-37	-7	12
Mar 2018	23	-60	-12	-49
Mar 2019	107	-76	-15	16
Mar 2020	87	-41	-33	13
Mar 2021	295	-4	-3	287
Mar 2022	231	-276	-23	-68
Mar 2023	157	-86	-30	41
Mar 2024	111	-118	-34	-41
Mar 2025	196	-139	-38	19
Mar 2026	203	-213	-46	-56

Key ratios

Historical financial ratios

Category	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	0	11	3	74	85	151	74	37	61	75	85	131
Inventory Days	36	56	50	58	36	34	47	76	95	153	102	137
Days Payable	108	161	149	148	92	79	131	116	130	140	93	148
Cash Conversion Cycle	-72	-94	-95	-16	30	107	-10	-2	26	89	93	120
Working Capital Days	-125	-112	-44	44	62	137	60	96	23	76	97	140
ROCE %	64%	60%	56%	58%	55%	48%	30%	29%	28%	29%	29%	26%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of CAPLIN POINT LAB LTD. (CAPLIPOINT)?

The reported market capitalisation for CAPLIN POINT LAB LTD. (CAPLIPOINT) is ₹17,493Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of CAPLIPOINT?

The current price shown for CAPLIN POINT LAB LTD. (CAPLIPOINT) on Fincrux is ₹2,301 with a 52-week high/low of ₹2,991/1,500.

What is the P/E ratio of CAPLIN POINT LAB LTD. (CAPLIPOINT)?

The stock P/E for CAPLIN POINT LAB LTD. (CAPLIPOINT) is 41.7 on Fincrux, with ROE at 20.4% and ROCE at 26.5%.

What were CAPLIPOINT latest quarterly results?

For Jun 2026, CAPLIN POINT LAB LTD. (CAPLIPOINT) reported sales ₹203 Cr and net profit ₹120 Cr (figures in ₹ crore unless noted).

What are CAPLIPOINT annual sales and net profit?

For TTM, CAPLIN POINT LAB LTD. (CAPLIPOINT) shows sales of ₹759 Cr and net profit of ₹420 Cr on the Fincrux profit & loss statement.

Who owns CAPLIN POINT LAB LTD. (CAPLIPOINT)?

Latest shareholding for CAPLIN POINT LAB LTD. (CAPLIPOINT) on Fincrux: Promoters 70.57% (Jun 2026), FIIs 5.76% (Jun 2026), DIIs 2.49% (Jun 2026), Public 21.19% (Jun 2026), No. of Shareholders 94,385% (Jun 2026).

Where can I find CAPLIN POINT LAB LTD. (CAPLIPOINT) financials?

CAPLIN POINT LAB LTD. (CAPLIPOINT) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show CAPLIPOINT balance sheet and cash flow?

Yes. The CAPLIN POINT LAB LTD. (CAPLIPOINT) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:14